News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Anal Cancer
November 4, 2025
Managing a Rare Cancer-What You Need to Know
Charles H. Weaver, MD
August 29, 2025
Immune Checkpoint Inhibitor Side Effects & Toxicity More Common Than Reported
Charles H. Weaver, MD
August 12, 2025
HPV Vaccine May Prevent Anal Cancer
Charles H. Weaver, MD
May 21, 2025
FDA Approves Zynyz (Retifanlimab-dlwr) for Advanced Anal Cancer
Charles H. Weaver, MD
June 29, 2022
Treatment of Precancerous Anal Lesions Reduces Anal Cancer Risk in People with HIV
Charles H. Weaver, MD
January 24, 2021
Retifanlimab Immunotherapy for Anal Cancer
Charles H. Weaver, MD
February 8, 2020
Understanding MSI-High and DNA Mismatch Repair (dMMR)
Charles H. Weaver, MD
November 19, 2019
Anal Cancer Rates Appear to Be On the Rise in the U.S.
Charles H. Weaver, MD
May 10, 2019
Anal Cancer Newsletter
Charles H. Weaver, MD
January 9, 2019
Intensity Modulated Radiation Reduces Side Effects for Patients with Anal Cancer
Charles H. Weaver, MD
August 28, 2018
Overview of Cancer of the Anus
Charles H. Weaver, MD
August 1, 2018
Women with CIN at Higher Risk for Anal Cancer and Other Cancers
Charles H. Weaver, MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
